OHB's Buy Case Survives a Bruising Session as Cash Conversion Takes Centre Stage
Published on 11/15/2026 at 08:11 | Editorial boerse-global.de
NuWays has reiterated its buy recommendation on OHB SE with an unchanged price target of EUR 340, a day after the Bremen-based space group's quarterly update sent the shares sharply lower. The stock fell 8.9% on Friday, with dpa-AFX attributing the pressure to disappointment over the nine-month figures published on Thursday.
At the heart of the sell-off was the adjusted operating result, which JPMorgan analyst David Perry flagged as coming in 7% below the analyst consensus. The adjusted free cash flow also fell short of expectations in the third quarter. Perry stuck to his assessment following the release.
Growth at the top line, strain at the bottom
OHB reported total output of EUR 946.5 million for the first nine months of 2026, an increase of 10% on the prior-year period. Adjusted EBITDA climbed 23% to EUR 99.7 million, while adjusted EBIT reached EUR 66.9 million — a gain of 30%.
The picture darkens further down the income statement. The period result dropped from EUR 24.4 million to EUR 19.1 million, a decline of 22%, and earnings per share fell 20%. That gap between adjusted operating progress and the profit actually attributable to shareholders is the crux of the debate now facing investors, and it explains why a set of headline growth numbers failed to win the market over.
Should investors sell immediately? Or is it worth buying OHB SE?
Order intake provides the counterweight. OHB put its order backlog at EUR 3.94 billion for the first nine months of 2026. Early in November, subsidiary OHB System AG secured the ESA development contract for the next generation of Copernicus Sentinel-3 topography satellites, a deal worth more than EUR 554 million with an option for a second satellite attached. Such wins give the growth case a concrete foundation, though converting them profitably — and converting them into cash — is a separate matter.
The guidance question
Management confirmed its full-year outlook on Thursday: total output of around EUR 1,400 million and an adjusted EBITDA margin of between 10.5% and 11.0%. That guidance addresses total output and the adjusted margin, not the reported period result, so it does little on its own to resolve the discrepancy between operating momentum and bottom-line profit.
For the bulls, the argument rests on improvements already delivered rather than on an assumed turnaround: adjusted EBITDA up 23% and adjusted EBIT up 30% are the strongest evidence against the disappointment over market expectations. What the optimistic reading still requires is proof that this operating progress feeds through to earnings and cash. A stronger cash inflow would bolster confidence in the operating trajectory; should it keep lagging, even further adjusted profit growth would not automatically dispel doubts.
OHB SE at a turning point? This analysis reveals what investors need to know now.
The cautious camp has more than missed consensus estimates to lean on. It can point to the actual trajectory of profit, and to the risk that if the gap persists while cash generation disappoints, operating growth alone may prove insufficient to justify a re-rating.
What to watch
The next fixed date on the corporate calendar is 28 January 2027, when OHB is due to publish its financial guidance for 2027. That will set a fresh benchmark for expectations. The constructive scenario would look most convincing if targets and subsequent financial delivery move in step — with the cash flow statement, rather than the order book, providing the decisive evidence.
Ad
OHB SE Stock: New Analysis - 15 November
Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
